Real-World Survival Effectiveness of Edaravone in Amyotrophic Lateral Sclerosis: A Propensity Score Weighted, Registry-based, Canada-wide Cohort Study

被引：0

作者：

Abrahao, Agessandro ^{[1
,2
]}

Vyas, Manav V. ^{[2
,3
]}

Parks, Andrea ^{[1
,2
]}

Hodgkinson, Victoria ^{[4
,5
]}

Dyck, Adrienna ^{[4
,5
]}

Benstead, Tim ^{[6
]}

Briemberg, Hannah ^{[7
,8
]}

Genge, Angela ^{[9
]}

Grant, Ian ^{[6
]}

Jewett, Gordon ^{[4
,5
]}

Johnston, Wendy ^{[11
]}

Kalra, Sanjay ^{[11
]}

Marrero, Alier ^{[12
,13
]}

Massie, Rami ^{[9
,10
]}

Melanson, Michel ^{[14
]}

O'Connell, Colleen ^{[6
,15
]}

Pfeffer, Gerald ^{[4
,5
]}

Schellenberg, Kerri L. ^{[16
]}

Taylor, Sean ^{[6
]}

Shoesmith, Christen ^{[17
,18
]}

Matte, Genevieve ^{[19
]}

Zinman, Lorne ^{[2
,3
]}

Korngut, Lawrence ^{[4
,5
]}

机构：

[1] Sunnybrook Med Ctr, Toronto, ON, Canada

[2] Univ Toronto, Toronto, ON, Canada

[3] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada

[4] Hotchkiss Brain Inst, Calgary, AB, Canada

[5] Univ Calgary, Calgary, AB, Canada

[6] Dalhousie Univ, Halifax, NS, Canada

[7] GF Strong Rehabil Ctr, Vancouver, BC, Canada

[8] Univ British Columbia, Vancouver, BC, Canada

[9] Montreal Neurol Hosp & Inst, Montreal, PQ, Canada

[10] McGill Univ, Montreal, PQ, Canada

[11] Univ Alberta, Edmonton, AB, Canada

[12] Dr Georges L Dumont Univ Hosp Ctr, Moncton, NB, Canada

[13] Univ Sherbrooke, Moncton, NB, Canada

[14] Queens Univ, Kingston, ON, Canada

[15] Stan Cassidy Ctr Rehabil, Fredericton, NB, Canada

[16] Univ Saskatchewan, Saskatoon, SK, Canada

[17] London Hlth Sci Ctr, London, ON, Canada

[18] Western Univ, London, ON, Canada

[19] Ctr Hosp Univ Montreal, Montreal, PQ, Canada

来源：

MUSCLE & NERVE | 2023年 / 68卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

116

引用

页码：S55 / S55

页数：1

共 41 条

[31] Associations of P Score With Real-World Survival Improvement Offered by Adjuvant Chemotherapy in Stage II Colon Cancer: A Large Population-Based Longitudinal Cohort Study
Liu, Qi
Shan, Zezhi
Luo, Dakui
Zhang, Sheng
Li, Qingguo
Li, Xinxiang
FRONTIERS IN ONCOLOGY, 2021, 11
[32] Real-world evidence of sotrovimab effectiveness for preventing severe outcomes in patients with COVID-19: A quality improvement propensity-matched retrospective cohort study of a pan-provincial program in Alberta, Canada
Farmer, Gregory
Sikdar, Khokan C.
Lo, Tkt
Conly, John
Slobodan, Jeremy
Ross, Jordan
James, Samantha
Usman, Hussain
Kemp, Kyle
Baker, Kristi
Doucette, Karen
Nijssen-Jordan, Cheri
Saxinger, Lynora M.
Joffe, A. Mark
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2024, 146
[33] Real-World Effectiveness of Nirmatrelvir/Ritonavir on Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Prevention: A Population-based Cohort Study in the Province of Quebec, Canada
Kabore, Jean-Luc
Laffont, Benoit
Diop, Mamadou
Tardif, Melanie R.
Turgeon, Alexis F.
Dumaresq, Jeannot
Luong, Me-Linh
Cauchon, Michel
Chapdelaine, Hugo
Claveau, David
Brosseau, Marc
Haddad, Elie
Benigeri, Mike
CLINICAL INFECTIOUS DISEASES, 2023, 77 (06) : 805 - 815
[34] HCV CURE BY IFN-FREE DIRECT ACTING ANTIVIRALS (DAAS) ARE ASSOCIATED WITH INCREASED SURVIVAL IN PATIENTS WITH HCV-RELATED HCC: A REAL-WORLD, PROPENSITY SCORE-MATCHED COHORT STUDY FROM THE US AND JAPAN
Dang, Hansen
Yeo, Yee Hui
Le, An K.
Nguyen, Brian T.
Ramrakhiani, Nathan
Tada, Toshifumi
Kumada, Takashi
Toyoda, Hidenori
Nguyen, Mindie H.
GASTROENTEROLOGY, 2019, 156 (06) : S1200 - S1201
[35] Propensity-score matching analysis for efficacy of platinum-based versus non-platinum chemotherapy in patients with "platinum-resistant" ovarian cancer (PROC): Real-world recent cohort study
Rumyantsev, A.
Israelyan, E. R.
Pokataev, I.
Glazkova, E.
Tsareva, A.
Ablyametova, A.
Letuchikh, A.
Ignatova, E.
Anokhin, A.
Abramov, M.
Shevchuk, A.
Tyulyandina, A.
Tjulandin, S.
ANNALS OF ONCOLOGY, 2024, 35 : S586 - S586
[36] Real-world effectiveness of early anti-SARS therapy in severely immunocompromised COVID-19 outpatients during the SARS-CoV-2 omicron variant era: a propensity score-adjusted retrospective cohort study
Pinargote-Celorio, Hector
Moreno-Perez, Oscar
Gonzalez-De-La-Aleja, Pilar
Llenas-Garcia, Jara
Perez-Crespo, Pedro Maria Martinez
Rodriguez-Diaz, Juan-Carlos
Martinez-Lopez, Belen
Gutierrez, Nicolas Merchante
Ramos-Rincon, Jose-Manuel
Merino, Esperanza
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (12) : 3248 - 3253
[37] Improved survival in real-world patients with advanced urothelial carcinoma: A multicenter propensity score-matched cohort study comparing a period before the introduction of pembrolizumab (2003-2011) and a more recent period (2016-2020)
Taguchi, Satoru
Kawai, Taketo
Nakagawa, Tohru
Miyakawa, Jimpei
Kishitani, Kenjiro
Sugimoto, Kazuma
Nakamura, Yu
Kamei, Jun
Obinata, Daisuke
Yamaguchi, Kenya
Kaneko, Tomoyuki
Yoshida, Kanae
Yamamoto, Sachi
Kakutani, Shigenori
Kanazawa, Koichiro
Sugihara, Yuriko
Tokunaga, Mayuko
Matsumoto, Akihiko
Uemura, Yukari
Akiyama, Yoshiyuki
Yamada, Yuta
Sato, Yusuke
Yamada, Daisuke
Enomoto, Yutaka
Nishimatsu, Hiroaki
Ishikawa, Akira
Tanaka, Yoshinori
Nagase, Yasushi
Fujimura, Tetsuya
Fukuhara, Hiroshi
Takahashi, Satoru
Kume, Haruki
INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (12) : 1462 - 1469
[38] A comparative effectiveness analysis applying a 3-way propensity score matching to real-world data from the MSBase registry in preparation for a cost-effectiveness model: patients switching within first-line agents or to either natalizumab or fingolimod in active relapsing-remitting multiple sclerosis
Spelman, Timothy
Havrdova, Eva
Horakova, Dana
Trojano, Maria
Lugaresi, Alessandra
Izquierdo, Guillermo
Grammond, Pierre
Duquette, Pierre
Alroughani, Raed
Pucci, Eugenio
Granella, Franco
Lechner-Scott, Jeannette
Sola, Patrizia
Ferraro, Diana
Grand'Maison, Francois
Terzi, Murat
Rozsa, Csilla
Boz, Cavit
Hupperts, Raymond
Van Pesch, Vincent
Oreja-Guevara, Celia
Jokubaitis, Vilija
Kalincik, Tomas
Butzkueven, Helmut
NEUROLOGY, 2018, 90
[39] Propensity-Score Matched Analysis of the Effectiveness of Baricitinib in Patients With Coronavirus Disease 2019 (COVID-19) Using Nationwide Real-World Data: An Observational Matched Cohort Study From the Japan COVID-19 Task Force
Tanaka, Hiromu
Chubachi, Shotaro
Namkoong, Ho
Sato, Yasunori
Asakura, Takanori
Lee, Ho
Azekawa, Shuhei
Otake, Shiro
Nakagawara, Kensuke
Fukushima, Takahiro
Watase, Mayuko
Sakurai, Kaori
Kusumoto, Tatsuya
Kondo, Yasushi
Masaki, Katsunori
Kamata, Hirofumi
Ishii, Makoto
Kaneko, Yuko
Hasegawa, Naoki
Ueda, Soichiro
Sasaki, Mamoru
Izumo, Takehiro
Inomata, Minoru
Miyazawa, Naoki
Kimura, Yasuhiro
Suzuki, Yusuke
Harada, Norihiro
Ichikawa, Masako
Takata, Tohru
Ishikura, Hiroyasu
Yoshiyama, Takashi
Kokuto, Hiroyuki
Murakami, Koji
Sano, Hirohito
Ueda, Tetsuya
Kuwahara, Naota
Fujiwara, Akiko
Ogura, Takashi
Inoue, Takashi
Asami, Takahiro
Mutoh, Yoshikazu
Nakachi, Ichiro
Baba, Rie
Nishi, Koichi
Tani, Mayuko
Kagyo, Junko
Hashiguchi, Mizuha
Oguma, Tsuyoshi
Asano, Koichiro
Nishikawa, Masanori
OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (07):
[40] Real-world cost-effectiveness of first-line gemcitabine plus nab-paclitaxel versus FOLFIRINOX in patients with advanced pancreatic cancer: A population-based retrospective cohort study in Ontario, Canada
Arciero, Vanessa
Luo, Jin
Parmar, Ambika
Dai, Wei Fang
Beca, Jaclyn M.
Raphael, Michael J.
Isaranuwatchai, Wanrudee
Habbous, Steven
Tadrous, Mina
Earle, Craig
Biagi, Jim
Mittmann, Nicole
Arias, Jessica
Gavura, Scott
Chan, Kelvin K.
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)

← 1 2 3 4 5 →